Founded in 2010, Montreux Capital Management (UK) is a highly specialised asset advisory firm which advises on investments exclusively in Health and Social Care in the UK. The Firm possesses deep knowledge and experience, advising companies in the specialist healthcare space.

£1Bn+

HEALTHCARE TRANSACTIONS

600+

INVESTORS

20+

 ACQUISITIONS

Improve & Develop

An entrepreneurial zeal, and a desire to be better is at the heart of everything we do.

Affiliations

Montreux is a proud member of the UK Sustainable Investment and Finance Association (UKSIF).

Innovate

As a company we value innovation, enterprise, and ethical business practices with an unrelenting commitment to the welfare of the Service Users within our Fund’s operating company.

Registration

Montreux Capital Management (UK) is an Appointed Representative of Sapia Partners LLP, which is authorised and regulated by the Financial Conduct Authority (FCA).

Social Implications

We offer socially impactful opportunities to the funds investors, transforming the lives of some of the most vulnerable people in our society.

Montreux Capital Management (UK) has honed its expertise in UK Specialist Care, becoming one of the leading actors in the space. Montreux Capital Management presents a team with deep experience and who have been working together since 2010.

Oliver Harris

Chief Executive Officer

Oliver Harris is the CEO of Montreux Capital Management (UK). Oliver graduated from the University of Surrey with a degree in Finance and Economics before beginning an expansive career, working with some of the world’s most respected financial institution. He previously worked in The City for the investment advisory wing of a large investment Bank before moving to Switzerland to work for a private Wealth Manager. Oliver has pursued a number of successful entrepreneurial ventures throughout his career. With deep familial ties in the care sector, Oliver has garnered a profound understanding of the industry from a very young age.

Gary Mullan

Partner

Gary’s is responsible for many of Montreux's strategic relationships. He has an extensive background in building and insurance brokering. Gary sits on the Boards of companies within Healthcare, Tech, Construction, and Financial Services. He has a large network of contacts from his many years working in commercial property.

Paul Nelson

Chief Financial Officer

Paul graduated from Royal Holloway with a degree in Economics before gaining his Chartered Accountancy qualification with BDO LLP. He spent 8 years there, going on to attain a senior management role, before joining Syngenta UK, the global Swiss agribusiness. At Syngenta, Paul worked in international reporting, revenue deal structuring, and M&A. Prior to joining Montreux, Paul spent 3 years at Nuffield Health where he was responsible for the Group’s cash flow management, reporting, and forecasting.
Paddy Evans

Paddy Evans

Investment Director

Prior to joining Montreux, Paddy worked for over 17 years in the healthcare team at Knight Frank, a leading global property consultancy.

As head of the corporate valuation and advisory team, he was involved in many of the leading transactions across all sectors of UK healthcare. Paddy brings a wealth of experience having advised investors, operators, funders, and developers, and remains a member of the Royal Institution of Chartered Surveyors.

Dr Amlan Basu

Chief Medical Officer

Having graduated in medicine from University College London, Amlan completed his specialist training at the Maudsley Hospital. He has held several high-profile positions in his career, notably as Clinical Director of Broadmoor Hospital where he was a Consultant Forensic Psychiatrist. Amlan held an honorary contract at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London for over 17 years, publishing a number of research papers in the fields of genetics, psychopharmacology and service development. He is a Fellow of the Royal College of Psychiatrists. He has been a member of the Expert Witness Institute for over 10 years and has provided expert evidence in a number of high-profile cases, including national inquiries. He has previously been a Non-Executive Director in the NHS.